Proteolipid protein is necessary in peripheral as well as central myelin

Neuron

Volumn 19, Issue 1, 1997, Pages 205-218

  Garbern, James Y ^a   Cambi, Franca ^b   Tang, Xue Ming ^b   Sima, Anders A F ^a   Vallat, Jean Michel ^c   Bosch, E Peter ^d   Lewis, Richard ^a   Shy, Michael ^a   Sohi, Jasloveleen ^a   Kraft, George ^e   Chen, Ke Lian ^f   Joshi, Indira ^f   Leonard, Debra G B ^f   Johnson, William ^g   Raskind, Wendy ^e   Dlouhy, Stephen R ^h   Pratt, Victoria ^h   Hodes, M Edward ^h   Bird, Thomas ^e   Kamholz, John ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c LIMOGES UNIVERSITY HOSPITAL   (France)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^h INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MYELIN PROTEIN; PROTEOLIPID PROTEIN;

ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMYELINATING DISEASE; GENE MUTATION; HUMAN; HUMAN TISSUE; MYELINATION; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SCHWANN CELL;

EID: 0030769418     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(00)80360-8     Document Type: Article

References (80)

1. Agrawal, H.C., and Agrawal, D. (1991). Proteolipid protein and DM-20 are synthesized by Schwann cells, present in myelin membrane, but they are not fatty acylated. Neurochem. Res. 16, 855-858.
2. Andre, M., Monin, P., Moret, C., Braun, M., and Picard, L. (1990). Pelizaeus-Merzbacher disease. Contribution of magnetic resonance imaging to an early diagnosis. J. Neuroradiol. 17, 216-221.
3. Asotra, K., and Macklin, W.B. (1993). Protein kinase C activity modulates myelin gene expression in enriched oligodendrocytes. J. Neurosci. Res. 34, 571-588.
4. Baer, R.D., and Johnson, E.W. (1965). Motor nerve conduction velocities in normal children. Arch. Phys. Med. 46, 698-704.
5. Bergoffen, J., Scherer, S.S., Wang, S., Scott, M.O., Bone, L.J., Paul, D.L., Chen, K., Lensch, M.W., Chance, P.F., and Fischbeck, K.H. (1993). Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 262, 2039-2042.
6. Bizzozero, O.A., Odykirk, T.S., McGarry, J.F., and Lees, M.B. (1989). Separation of the major proteins of central and peripheral nervous system myelin using reversed-phase high-performance liquid chromatography. Anal. Biochem. 180, 59-65.
7. Boison, D., Bussow, H., D'Urso, D., Muller, H.W., and Stoffel, W. (1995). Adhesive properties of proteolipid protein are responsible for the compaction of CNS myelin sheaths. J. Neurosci. 15, 5502-5513.
8. Boulloche, J., and Aicardi, J. (1986). Pelizaeus-Merzbacher disease: clinical and nosological study. J. Child. Neurol. 1, 233-239.
9. Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
10. Cambi, F., Tang, X.M., Cordray, P., Fain, P.R., Keppen, L.D., and Barker, D.F. (1996). Refined genetic mapping and proteolipid point mutation analysis in X-linked pure hereditary spastic paraplegia. Neurology 46, 1112-1117.
11. Caro, P.A., and Marks, H.G. (1990). Magnetic resonance imaging and computed tomography in Pelizaeus-Merzbacher disease. Magn. Reson. Imaging 8, 791-796.
12. Chance, P.F., Alderson, M.K., Leppig, K.A., Lensch, M.W., Matsunami, N., Smith, B., Swanson, P.D., Odelberg, S.J., Disteche, C.M., and Bird, T.D. (1993). DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 72, 143-151.
13. Chen, K.-L., Wang, Y.L., Dodson, L.A., Rennert, H., Mochan, B.S., Wilson, R.B., and Kant, J.A. (1996). Normalized Southern hybridization to enhance testing for Charcot-Marie-Tooth disease, Type 1A. Mol. Diag. 1, 65-71.
14. Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
15. Diehl, H.J., Schaich, M., Budzinski, R.M., and Stoffel, W. (1986). Individual exons encode the integral membrane domains of human myelin proteolipid protein [published erratum appears in Proc. Natl. Acad. Sci. USA (1991). 86, 617-618]. Proc. Natl. Acad. Sci. USA 83, 9807-9811.
16. Duchala, C.S., Asotra, K., and Macklin, W.B. (1995). Expression of cell surface markers and myelin proteins in cultured oligodendrocytes from neonatal brain of rat and mouse: a comparative study. Dev. Neurosci. 17, 70-80.
17. Gamstorp, I. (1963). Normal conduction velocity of ulnar, median and peroneal nerves in infancy, childhood and adolescence. Acta Pediatr. Scand. Suppl. 146, 68-76.
18. Giese, K.P., Martini, R., Lemke, G., Soriano, P., and Schachner, M. (1992). Mouse PO gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 71, 565-576.
19. Gow, A., and Lazzarini, R.A. (1996). A cellular mechanism governing the severity of Pelizaeus-Merzbacher disease. Nature Genet. 13, 422-428.
20. Gow, A., Friedrich, V.L., Jr., and Lazzarini, R. A. (1994). Many naturally occurring mutations of myelin proteolipid protein impair its intracellular transport. J. Neurosci. Res. 37, 574-583.
21. Griffiths, I.R., Schneider, A., Anderson, J., and Nave, K.-A. (1995). Transgenic and natural mouse models of proteolipid protein (PLP)-related dysmyelination and demyelination. Brain Pathol. 5, 275-281.
22. Gupta, S.K., Pringle, J., Poduslo, J.F., and Mezei, C. (1991). Levels of proteolipid protein mRNAs in peripheral nerve are not under stringent axonal control. J. Neurochem. 56, 1754-1762.
23. Harding, B., Ellis, D., and Malcolm, S. (1995). A case of Pelizaeus-Merzbacher disease showing increased dosage of the proteolipid protein gene. Neuropathol. Appl. Neurobiol. 21, 111-115.
24. Hayasaka, K., Himoro, M., Sato, W., Takada, G., Uyemura, K., Shimizu, N., Bird, T.D., Conneally, P.M., and Chance, P.F. (1993a). Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the myelin PO gene. Nature Genet. 5, 31-34.
25. Hayasaka, K., Himoro, M., Sawaishi, Y., Nanao, K., Takahashi, T., Takada, G., Nicholson, G.A., Ouvrier, R.A., and Tachi, N. (1993b). De novo mutation of the myelin PO gene in Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III). Nature Genet. 5, 266-268.
26. Helynck, G., Luu, B., Nussbaum, J.L., Picken, D., Skalidis, G., Trifilieff, E., Van Dorsselaer, A., Seta, P., Sandeaux, R., Gavach, C., Heitz, F., Simon, D., and Spach, G. (1983). Brain proteolipids. Isolation, purification and effect on ionic permeability of membranes. Eur. J. Biochem. 133, 689-695.
27. Hodes, M.E., Pratt, V.M., and Dlouhy, S.R. (1993). Genetics of Pelizaeus-Merzbacher disease. Dev. Neurosci. 15, 383-394.
28. Ikenaka, K., Kagawa, T., and Midoshiba, K. (1992). Selective expression of DM-20, an alternatively spliced myelin proteolipid protein gene product, in developing nervous system and in nonglial cells. J. Neurochem. 58, 2248-2253.
29. Iyoda, K., Tanaka, J., Suzuki, Y., Nagao, Y., and Ohtahara, S. (1988). Histopathologic and biochemical analysis of classic Pelizaeus-Merzbacher disease. Pediatr. Neurol. 4, 252-254.
30. Jasek, F., Chateil, J.F., Fontan, D., Diard, F., and Desforges, J. (1990). [Pelizaeus-Merzbacher disease: the diagnostic contribution of MRI]. Arch. Fr. Pediatr. 47, 265-269.
31. Journel, H., Roussey, M., Gandon, Y., Allaire, C., Carsin, M., and le Marec, B. (1987). Magnetic resonance imaging in Pelizaeus-Merzbacher disease. Neuroradiology 29, 403-405.
32. Kaku, D.A., Parry, G.J., Malamut, R., Lupski, J.R., and Garcia, C.A. (1993). Nerve conduction studies in Charcot-Marie-Tooth polyneuropathy associated with a segmental duplication of chromosome 17. Neurology 43, 1806-1808.
33. Kamholz, J., Sess, M., Scherer, S., Vogelbacker, H., Mokuno, K., Baron, P., Wrabetz, L., Shy, M., and Pleasure, D. (1992). Structure and expression of proteolipid protein in the peripheral nervous system. J. Neurosci. Res. 31, 231-244.
34. Keller, E.B., and Noon, W.A. (1984). Intron splicing: a conserved internal signal in introns of animal pre-mRNAs. Proc. Natl. Acad. Sci. USA 81, 7417-7420.
35. Kimura, J. (1974). F-wave velocity in the central segment of the median and ulnar nerves: a study in normal subjects and in patients with Charcot-Marie-Tooth disease. Neurology 24, 539-546.
36. Klugmann, M., Schwab, M.H., Pühlhofer, A., Schneider, A., Zimmermann, F., Griffiths, I.R., and Nave, K.-A. (1997). Assembly of CNS myelin in the absence of proteolipid protein. Neuron 18, 59-70.
37. Kobayashi, H., Hoffman, E.P., and Marks, H.G. (1994). The rumpshaker mutation in spastic paraplegia. Nature Genet. 7, 351-352. Letter.
38. Koeppen, A.H., Ronca, N.A., Greenfield, E.A., and Hans, M.B. (1987). Defective biosynthesis of proteolipid protein in Pelizaeus-Merzbacher disease. Ann. Neurol 21, 159-170.
39. Laemmli, U.K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
40. Lees, M.B., and Bizzozero, O.A. (1992). Structure and acylation of proteolipid protein. In Myelin: Biology and Chemistry, R. E. Martenson, ed. (Boca Raton, Florida: CRC Press), pp. 237-255.
41. Lemke, G. (1992). Myelin and myelination. In An Introduction to Molecular Neurobiology, Z. W. Hall, ed. (Sunderland, Massachusetts: Sinauer Associates, Inc.), pp. 281-309.
42. Markand, O.N., Garg, B.P., DeMyer, W.E., Warren, C., and Worth, R.M. (1982). Brain stem auditory, visual and somatosensory evoked potentials in leukodystrophies. Electroencephalogr. Clin. Neurophysiol. 54, 39-48.
43. Martini, R., Mohajeri, M.H., Kasper, S., Giese, K.P., and Schachner, M. (1995a). Mice doubly deficient in the genes for PO and myelin basic protein show that both proteins contribute to the formation of the major dense line in peripheral nerves characteristic of inherited human neuropathies. J. Neurosci. 15, 4488-4495.
44. Martini, R., Zielasek, J., Toyka, K.V., Giese, K.P., and Schachner, M. (1995b). Protein zero (PO)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nature Genet. 11, 281-286.
45. Morell, P., Wiggins, R.C., and Gray, M.J. (1975). Polyacrylamide gel electrophoresis of myelin proteins: a caution. Anal. Biochem. 68, 148-154.
46. Nadon, N.L., and Duncan, I.D. (1995). Gene expression and oligodendrocyte development in the myelin deficient rat. J. Neurosci. Res. 41, 96-104.
47. Nadon, N.L., Arnheiter, H., and Hudson, L.D. (1994). A combination of PLP and DM20 transgenes promotes partial myelination in the jimpy mouse. J. Neurochem. 63, 822-833.
48. Orita, M., Suzuki, Y., Sekiya, T., and Hayashi, K. (1989). Rapid detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5, 874-879.
49. Osaka, H., Kawanishi, C., Inoue, K., Uesugi, H., Hiroshi, K., Nishiyama, K., Yamada, Y., Suzuki, K., Kimura, S., and Kosaka, K. (1995). Novel nonsense proteolipid protein gene mutation as a cause of X-linked spastic paraplegia in twin males. Biochem. Biophys. Res. Commun. 215, 835-841.
50. Panayiotopoulos, C.P., and Chroni, E. (1996). F-waves in clinical neurophysiology: a review, methodological issues and overall value in peripheral neuropathies. Electroencephalogr. Clin. Neurophysiol. 101, 365-374.
51. Pham-Dinh, D., Birling, M.C., Roussel, G., Dautigny, A., and Nussbaum, J.L. (1991). Proteolipid DM-20 predominates over PLP in peripheral nervous system. Neuroreport 2, 89-92.
52. Pratt, V.M., Kiefer, J.R., Lähdetie, J., Schleutker, J., Hodes, M.E., and Dlouhy, S.R. (1993). Linkage of a new mutation in the proteolipid protein (PLP) gene to Pelizaeus-Merzbacher disease (PMD) in a large Finnish kindred. Am. J. Hum. Genet. 52, 1053-1056.
53. Puckett, C., Hudson, L., Ono, K., Friedrich, V., Benecke, J., Dubois-Dalcq, M., and Lazzarini, R.A. (1987). Myelin-specific proteolipid protein is expressed in myelinating Schwann cells but is not incorporated into myelin sheaths. J. Neurosci. Res. 18, 511-518.
54. Raskind, W.H., Williams, C.A., Hudson, L.D., and Bird, T.D. (1991). Complete deletion of the proteolipid protein gene (PLP) in a family with X-linked Pelizaeus-Merzbacher disease. Am. J. Hum. Genet. 49, 1355-1360.
55. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual. (Cold Spring Harbor, New York: Cold Spring Harbor Press), p. 1659.
56. Saugier-Veber, P., Munnich, A., Bonneau, D., Rozet, J.M., LeMerrer, M., Gil, R., and Boesplug-Tanguy, O. (1994). X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nature Genet. 6, 257-262.
57. Schindler, P., Luu, B., Sorokine, O., Trifilieff, E., and Van Dorsselaer, A. (1990). Developmental study of proteolipids in bovine brain: a novel proteolipid and DM-20 appear before proteolipid protein (PLP) during myelination. J. Neurochem. 55, 2079-2085.
58. Schneider, A., Griffiths, I.R., Readhead, C., and Nave, K.-A. (1995). Dominant-negative action of the jimpy mutation in mice complemented with an autosomal transgene for myelin proteolipid protein. Proc. Natl. Acad. Sci. USA 92, 4447-4451.
59. Seitelberger, F. (1970). Pelizaeus-Merzbacher disease. In Handbook of Clinical Neurology, P. J. Vinken and G. W. Bruyn, ed. (Amsterdam: North Holland), pp. 150-220.
60. Seitelberger, F. (1984). Structural manifestations of leukodystrophies. Neuropediatrics 15, 53-61.
61. Seitelberger, F. (1995). Neuropathology and genetics of Pelizaeus-Merzbacher disease. Brain Pathol. 5, 267-273.
62. Sima, A.A.F., and Blaivas, M. (1997). The pathology of peripheral nerve. In Neuropathology, J. Garcia, P. McKeevar, and A. A. F. Sima, eds. (Philadelphia: Mosby and Co.), in press.
63. Sinoway, M.P., Kitagawa, K., Timsit, S., Hashim, G.A., and Colman, D.R. (1994). Proteolipid protein interactions in transfectants:implications for myelin assembly. J. Neurosci. Res. 37, 551-562.
64. Sistermans, E.A., Dewijs, I.J., Decoo, R.F.M., Smit, L.M.E., Menko, F.H., and Van Oost, B.A. (1996). A (G-to-A) mutation in the initiation codon of the proteolipid protein gene causing a relatively mild form of Pelizaeus-Merzbacher disease in a Dutch family. Hum. Genet. 97, 337-339.
65. Skoff, R.P. (1995). Programmed cell death in the dysmyelinating mutants. Brain Pathol. 5, 283-288.
66. Sugiyama, N., Onishi, H., Suzuki, K., Kimura, S., Miyakawa, N., Hanihara, T., Yamada, Y., and Kosada, K. (1996). Proteolipid protein gene analysis in Pelizaeus-Merzbacher disease. Am. J. Hum. Genet. 59, A276.
67. Sunderland, S. (1968). Nerve and Nerve Injuries. (Baltimore: Williams & Wilkins Co.), pp. 277-280.
68. Timsit, S.G., Bally-Cuif, L., Colman, D.R., and Zalc, B. (1992). DM-20 mRNA is expressed during the embryonic development of the nervous system of the mouse. J. Neurochem. 58, 1172-1175.
69. Timsit, S., Martinez, S., Allinquant, B., Peyron, F., Puelles, L., and Zalc, B. (1995). Oligodendrocytes originate in a restricted zone of the embryonic ventral neural tube defined by DM-20 m RNA expression. J. Neurosci. 15, 1012-1024.
70. Tokuyasu, K.T. (1973). A technique for ultracryotomy of cell suspensions and tissues. J. Cell Biol. 57, 551-565.
71. Trapp, B.D., Nishiyama, A., Cheng, D., and Macklin, W. (1997). Differentiation and death of premyelinating oligodendrocytes in developing rodent brain. J. Cell Biol. 137, 459-468.
72. Trofatter, J.A., Dlouhy, S.R., DeMyer, W., Conneally, P.M., and Hodes, M.E. (1989). Pelizaeus-Merzbacher disease: tight linkage to proteolipid protein gene exon variant. Proc. Natl. Acad. Sci. USA 86, 9427-9430.
73. Vallat, J.M., Sindou, P., Preux, P.M., Tabaruad, F., Milor, A.M., Couratier, P., LeBeurn, E., and Brice, A. (1996). Ultrastructural PMP22 expression in inherited demyelinating neuropathies. Ann. Neural. 39, 813-817.
74. Wang, P.J., Young C., Liu, H.M., Chang, Y.C., and Shen, Y.Z. (1995). Neurophysiologic studies and MRI in Pelizaeus-Merzbacher disease: comparison of classic connatal forms. Pediatr. Neurol. 12, 47-53.
75. Wiggins, R.C., Benjamins, J.A., and Morell, P. (1975). Appearance of myelin proteins in rat sciatic nerve during development. Brain Res. 89, 99-106.
76. Wilkus, R.J., and Farrell, D.F. (1976). Electrophysiologic observations in the classical form of Pelizaeus-Merbacher disease. Neurology 26, 1042-1045.
77. Yoshida, M., and Colman, D.R. (1996). Parallel evolution and coexpression of the proteolipid proteins and protein zero in vertebrate myelin. Neuron 16, 1115-1126.
78. Young, R.R., and Shahani, B.T. (1978). Clinical value and limitations of F-wave determination. Muscle Nerve 1, 248-249.
79. Yu, W.P., Collarini, E.J., Pringle, N.P., and Richardson, W.D. (1994). Embryonic expression of myelin genes: evidence for a focal source of oligodendrocyte precursors in the ventricular zone of the neural tube. Neuron 12, 1353-1362.
80. Zeman, W., DeMyer, W., and Falls, H.F. (1964). Pelizaeus-Merzbacher disease: a study in nosology. J. Neuropathol. Exp. Neurol. 23, 334-354.